title: Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
authors.forename: Geertruida H
authors.initials: GH
authors.lastname: de Bock
authors.forename: Rob A E M
authors.initials: RA
authors.lastname: Tollenaar
authors.forename: Hadewych
authors.initials: H
authors.lastname: Papelard
authors.forename: Theodora P M
authors.initials: TP
authors.lastname: Vliet Vlieland
authors.forename: Peter
authors.initials: P
authors.lastname: Devilee
authors.forename: Cornelis J
authors.initials: CJ
authors.lastname: Cornelisse
authors.forename: Jan P
authors.initials: JP
authors.lastname: Vandenbroucke
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000235:genetics; D016022:Case-Control Studies; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D016017:Odds Ratio; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D003278:Contraceptives, Oral, Hormonal